vs
Side-by-side financial comparison of IDEAYA Biosciences, Inc. (IDYA) and PARK NATIONAL CORP (PRK). Click either name above to swap in a different company.
IDEAYA Biosciences, Inc. is the larger business by last-quarter revenue ($207.8M vs $168.3M, roughly 1.2× PARK NATIONAL CORP). IDEAYA Biosciences, Inc. runs the higher net margin — 57.4% vs 25.3%, a 32.0% gap on every dollar of revenue. PARK NATIONAL CORP produced more free cash flow last quarter ($191.9M vs $142.2M).
IDEAYA Biosciences, Inc. is a clinical-stage biotechnology company focused on oncology, developing targeted therapies and synthetic lethality treatments for patients with genetically defined cancers. It advances a pipeline of candidates across multiple tumor types, partnering with industry stakeholders to accelerate global access to innovative cancer care solutions.
National Retail Systems, Inc. (NRS) includes Keystone Freight Corp. & National Retail Transportation, Inc. (NRT). NRS is an asset based 3PL founded in 1952. It is headquartered in Lyndhurst, New Jersey, United States.
IDYA vs PRK — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $207.8M | $168.3M |
| Net Profit | $119.2M | $42.6M |
| Gross Margin | — | — |
| Operating Margin | 52.2% | — |
| Net Margin | 57.4% | 25.3% |
| Revenue YoY | — | 2.2% |
| Net Profit YoY | 330.1% | 10.4% |
| EPS (diluted) | $1.33 | $2.62 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $168.3M | ||
| Q3 25 | $207.8M | $169.5M | ||
| Q2 25 | — | $168.7M | ||
| Q1 25 | — | $157.9M | ||
| Q4 24 | — | $164.7M | ||
| Q3 24 | $0 | $170.3M | ||
| Q2 24 | $0 | $157.7M | ||
| Q1 24 | $0 | $152.8M |
| Q4 25 | — | $42.6M | ||
| Q3 25 | $119.2M | $47.2M | ||
| Q2 25 | — | $48.1M | ||
| Q1 25 | — | $42.2M | ||
| Q4 24 | — | $38.6M | ||
| Q3 24 | $-51.8M | $38.2M | ||
| Q2 24 | $-52.8M | $39.4M | ||
| Q1 24 | $-39.6M | $35.2M |
| Q4 25 | — | — | ||
| Q3 25 | 52.2% | 34.3% | ||
| Q2 25 | — | 35.2% | ||
| Q1 25 | — | 32.4% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 27.4% | ||
| Q2 24 | — | 30.6% | ||
| Q1 24 | — | 27.8% |
| Q4 25 | — | 25.3% | ||
| Q3 25 | 57.4% | 27.8% | ||
| Q2 25 | — | 28.5% | ||
| Q1 25 | — | 26.7% | ||
| Q4 24 | — | 23.5% | ||
| Q3 24 | — | 22.4% | ||
| Q2 24 | — | 25.0% | ||
| Q1 24 | — | 23.0% |
| Q4 25 | — | $2.62 | ||
| Q3 25 | $1.33 | $2.92 | ||
| Q2 25 | — | $2.97 | ||
| Q1 25 | — | $2.60 | ||
| Q4 24 | — | $2.38 | ||
| Q3 24 | $-0.60 | $2.35 | ||
| Q2 24 | $-0.68 | $2.42 | ||
| Q1 24 | $-0.53 | $2.17 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $786.9M | $233.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.1B | $1.4B |
| Total Assets | $1.2B | $9.8B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $233.5M | ||
| Q3 25 | $786.9M | $218.9M | ||
| Q2 25 | — | $193.1M | ||
| Q1 25 | — | $237.6M | ||
| Q4 24 | — | $160.6M | ||
| Q3 24 | $920.0M | $201.7M | ||
| Q2 24 | $701.7M | $261.5M | ||
| Q1 24 | $698.8M | $306.1M |
| Q4 25 | — | $1.4B | ||
| Q3 25 | $1.1B | $1.3B | ||
| Q2 25 | — | $1.3B | ||
| Q1 25 | — | $1.3B | ||
| Q4 24 | — | $1.2B | ||
| Q3 24 | $1.2B | $1.2B | ||
| Q2 24 | $931.7M | $1.2B | ||
| Q1 24 | $935.3M | $1.2B |
| Q4 25 | — | $9.8B | ||
| Q3 25 | $1.2B | $9.9B | ||
| Q2 25 | — | $9.9B | ||
| Q1 25 | — | $9.9B | ||
| Q4 24 | — | $9.8B | ||
| Q3 24 | $1.2B | $9.9B | ||
| Q2 24 | $973.7M | $9.9B | ||
| Q1 24 | $961.5M | $9.9B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $142.2M | $198.3M |
| Free Cash FlowOCF − Capex | $142.2M | $191.9M |
| FCF MarginFCF / Revenue | 68.4% | 114.1% |
| Capex IntensityCapex / Revenue | 0.0% | 3.8% |
| Cash ConversionOCF / Net Profit | 1.19× | 4.65× |
| TTM Free Cash FlowTrailing 4 quarters | $13.5M | $328.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $198.3M | ||
| Q3 25 | $142.2M | $52.6M | ||
| Q2 25 | — | $49.7M | ||
| Q1 25 | — | $37.9M | ||
| Q4 24 | — | $178.8M | ||
| Q3 24 | $-49.2M | $43.8M | ||
| Q2 24 | $-32.9M | $50.9M | ||
| Q1 24 | $-43.8M | $35.0M |
| Q4 25 | — | $191.9M | ||
| Q3 25 | $142.2M | $51.1M | ||
| Q2 25 | — | $48.4M | ||
| Q1 25 | — | $36.8M | ||
| Q4 24 | — | $169.7M | ||
| Q3 24 | $-49.7M | $41.7M | ||
| Q2 24 | $-33.9M | $49.0M | ||
| Q1 24 | $-45.1M | $31.9M |
| Q4 25 | — | 114.1% | ||
| Q3 25 | 68.4% | 30.1% | ||
| Q2 25 | — | 28.7% | ||
| Q1 25 | — | 23.3% | ||
| Q4 24 | — | 103.0% | ||
| Q3 24 | — | 24.5% | ||
| Q2 24 | — | 31.1% | ||
| Q1 24 | — | 20.8% |
| Q4 25 | — | 3.8% | ||
| Q3 25 | 0.0% | 0.9% | ||
| Q2 25 | — | 0.8% | ||
| Q1 25 | — | 0.7% | ||
| Q4 24 | — | 5.6% | ||
| Q3 24 | — | 1.2% | ||
| Q2 24 | — | 1.2% | ||
| Q1 24 | — | 2.1% |
| Q4 25 | — | 4.65× | ||
| Q3 25 | 1.19× | 1.11× | ||
| Q2 25 | — | 1.03× | ||
| Q1 25 | — | 0.90× | ||
| Q4 24 | — | 4.63× | ||
| Q3 24 | — | 1.14× | ||
| Q2 24 | — | 1.29× | ||
| Q1 24 | — | 0.99× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
